Correlation Between Cue Biopharma and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and VistaGen Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and VistaGen Therapeutics.
Diversification Opportunities for Cue Biopharma and VistaGen Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cue and VistaGen is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and VistaGen Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to generate 4.69 times more return on investment than VistaGen Therapeutics. However, Cue Biopharma is 4.69 times more volatile than VistaGen Therapeutics. It trades about 0.14 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 76.00 in Cue Biopharma on August 31, 2024 and sell it today you would earn a total of 46.00 from holding Cue Biopharma or generate 60.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. VistaGen Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| VistaGen Therapeutics |
Cue Biopharma and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and VistaGen Therapeutics
The main advantage of trading using opposite Cue Biopharma and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| VistaGen Therapeutics vs. Cue Biopharma | VistaGen Therapeutics vs. Eliem Therapeutics | VistaGen Therapeutics vs. Inhibrx | VistaGen Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |